Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBA-7371 EBA Study in Pulmonary TB
NCT04176250Phase 2Completed
- Sponsor
- Gates Medical Research Institute
- Start
- Jan 2020
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TBA-7371 in pulmonary tuberculosis (TB), sponsored by Gates Medical Research Institute. Started Jan 2020; status: completed.
02
Drugs
TBA-7371
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT04176250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04176250.